Dr Kara Cattani Thompson, PHD | |
4592 Spruce Cir, Cedar Hills, UT 84062-7703 | |
(801) 361-2671 | |
Not Available |
Full Name | Dr Kara Cattani Thompson |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 4592 Spruce Cir, Cedar Hills, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922296276 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 5412513-2501 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kara Cattani Thompson, PHD 1500 Wsc, Brigham Young University, Provo, UT 84602 Ph: (801) 422-3035 | Dr Kara Cattani Thompson, PHD 4592 Spruce Cir, Cedar Hills, UT 84062-7703 Ph: (801) 361-2671 |
News Archive
Macrophages are effective weapons used by our immune system to absorb and digest pathogenic intruders. Some bacteria, however, can subvert this defence mechanism and even multiply within the macrophages.
miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.
Insilico Medicine, a Baltimore-based leader in artificial intelligence for drug discovery and biomarker development, is pleased to announce a multi-year drug development agreement with the biotechnology company Juvenescence AI Limited.
Loughborough University researchers are hoping a technology they developed to quickly screen liquids for microorganisms can be adapted to provide rapid testing for Covid-19.
Simple yet structured exercise can significantly improve kidney disease patients' quality of life as well as decrease their pain, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
› Verified 6 days ago